Anderson ME

INGREDIENTS Water/Aqua, Glycerin,Butylene Glycol Dicaprylate/Dicaprate, Dipropylene Glycol, Pentaerythrityl Tetraethylhexanoate, Niacinamide, Squalane, C9-12 Alkane, Panthenol, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Sodium Hyaluronate, Sodium Acetylated Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate, Bisabolol, Ferulic Acid, Potassium Cetyl Phosphate,1,2 Hexanediol, Hydroxyacetophenone, Glutathione, Tocopherol, Vaccinium Macrocarpon (Cranberry) Fruit Extract, Allantoin, Chamomilla Recutita (Matricaria) Flower Extract, Malt Extract, Ubiquinone, Oryza Sativa (Rice) Bran Extract, Tromethamine, Isohexadecane, Butylene Glycol, Xanthan Gum,3-O-Ethyl Ascorbic Acid, Tocopheryl Acetate, Sorbitan Oleate, Adenosine, t-Butyl Alcohol, Glucose, Ascorbic Acid, C14-22 Alcohols, Glyceryl Acrylate/Acrylic Acid Copolymer, Polysorbate 80,C12-20 Alkyl Glucoside, Polyacrylate Crosspolymer-6,Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Disodium EDTA

Medication 14-28 days
doi: 10.1016/j.phrs.2019.02.018 9 AntherieuS.ChesneC.LiR.CamusS.LahozA.PicazoL.et al
While GHK-Cu treatment alone did not cause any visible histological changes or toxicity, pretreatment with GHK-Cu markedly attenuated these pathological alterations, resulting in a significantly reduced lung injury score compared to the LPS-only group
John Salerno carefully tailors each IV formula to meet the specific needs of individuals, targeting factors such as inflammation and deficiencies in critical vitamins and minerals that may contribute to depressive symptoms